Rajesh Solanki

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis, Tuberculosis Prevention +7

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis

Chandrasekaran Padmapriyadarsini, Vikram Vohra, Anuj Bhatnagar et al. · Clinical Infectious Diseases · 2022 · 108 citations · Full text

A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens

Neeraj Raizada, Kuldeep Singh Sachdeva, Devendra Singh Chauhan et al. · PLoS ONE · 2014 · 58 citations · Full text

Psychological well-being and burden in caregivers of patients with schizophrenia

Aditya Gupta, Rajesh Solanki, GD Koolwal et al. · International Journal of Medical Science and Public Health · 2014 · 46 citations

Quality Of Life, Family Medicine, Indian Studies +12

Treatment outcome of andardized regimen in patients with multidrug resistant tuberculosis

Kalpesh Kumar Jain, Mira Desai, Rajesh Solanki et al. · Journal of Pharmacology and Pharmacotherapeutics · 2014 · 40 citations · Full text